medigraphic.com
ISSN 1684-1824 (Electronic)

2019, Number 5

<< Back Next >>

Rev Méd Electrón 2019; 41 (5)

Neurosurgical advances and molecular biology in the treatment of glioblastoma multiforme

Sierra BEM, León PMQ, Morales FMA

Language: Portugués
References: 26
Page: 1230-1241
PDF size: 490.21 Kb.


ABSTRACT

Despite advances in radiotherapy, chemotherapy and aggressive surgical resection treatments in glioblastoma multiforme, the prognosis remains discouraging. With the current review, the main alternatives for the treatment of glioblastoma multiforme are described in a current context. The authors reviewed the main articles published in English, in high impact journals worldwide, on the main advances in the treatment of this tumor. The main neurosurgical advances in the resection of glioblastoma were addressed, as well as the implications of tumor stem cells in the genesis and control of tumor proliferation, as well as the effect of hypoxia on tumor cell dynamics. DNA alterations causing tumor genesis and PTEN mutations in glioblastoma are also explained.


REFERENCES

  1. Llongueras J. Na+/H+ exchanger NHE9 affects tumor progression of human glioblastomas by altering endosomal pH (893.34). The Based J [Internet]. 2014[citado 02/08/2017];28(1). Disponible en: https://www.fasebj.org/doi/abs/10.1096/fasebj.28.1_supplement.893.34

  2. Lara-Velázquez M. Advances in Brain Tumor Surgery for Glioblastoma in Adults. Brain Sci. 2017;7(12) . Citado en PubMed:PMID:29261148.

  3. Gronych J, Pfister E, Jones D. Connect Four with Glioblastoma Stem Cell Factors. Cell.2014;157(3). Citado en PubMed:PMID:24766799.

  4. Pengcheng Li, Chun Zhou, Lunshan Xu, et al. Hypoxia Enhances Stemness of Cancer Stem Cells in Glioblastoma: An In Vitro Study. Int J Med Sci. 2013;10(4):399- 407. Citado en PubMed:PMID: 23471193.

  5. Gómez-Vega JC, Ocampo Navia MI, Feo Lee O. Epidemiología y caracterización general de los tumores cerebrales primarios en el adulto. Univ Med [Internet]. 2019[citado 03/08/2018];60(1). Disponible en: http://dx.doi.org/10.11144/Javeriana.umed60-1.cere

  6. WILEY J & SONS. Cirugía guiada por imágenes para la resección de tumores cerebrales. Cochrane Database of Systematic Reviews[Internet]. 2014;1. Disponible en: https://www.cochrane.org/es/CD012788/cirugia-guiada-por-imagenes-para-lostumores- cerebrales

  7. Valenzuela R. Nuevas terapias en el manejo de los gliomas de alto grado. Rev Med Clin Condes [Internet]. 2017 [citado 03/08/2018];28(3):401-8. Disponible en: https://www.sciencedirect.com/science/article/pii/S0716864017300652

  8. Kut C, Chaichana KL, Xi J, et al. Detection of human brain cancer infiltration ex vivo and in vivo using quantitative optical coherence tomography. Sci Transl Med. 2015;7(292). Citado en PubMed:PMID:26084803.

  9. Iftimia N, Hammer DX, Mujat M, et al. Optical coherence tomography imaging for cancer diagnosis and therapy guidance. Conf Proc IEEE Eng Med Biol Soc. 2009;2009: 4067–69. Citado en PubMed:PMID:19964101.

  10. Sardi Correa C, Acosta Cadavid C, Rodríguez Gómez AM, et al. Grosor coroideo central en sujetos hispanos sanos medido por tomografía de coherencia óptica con imagen de profundidad mejorada. Rev Mex Oftalmol [Internet]. 2017 [citado 03/12/2018];91(1):2-8. Disponible en: https://www.sciencedirect.com/science/article/pii/S018745191600024X

  11. Moore GE, Peyton WT, French LA, et al. The clinical use of fluorescein in neurosurgery; the localization of brain tumors. J Neurosurg. 1948;5(4):392–98. Citado en PubMed:PMID:18872412.

  12. Vidal-Sicart S, Valdés Olmos R, Nieweg O E, et al. De la imagen intervencionista a la guía intraoperatoria: nuevas perspectivas combinando herramientas avanzadas y navegación con la cirugía radioguiada. Rev Esp Med Nucl Imagen Mol [Internet]. 2018[citado 03/11/2018];37(1):28-40. Disponible en: https://www.sciencedirect.com/science/article/pii/S2253654X17301063

  13. Díez Valle R, Slof J, Galván J, et al. Estudio observacional retrospectivo sobre la efectividad del ácido5-aminolevulínico en la cirugía de los gliomas malignos en España. Neurología[Internet]. 2014[citado 08/08/2018];29(3):131-38. Disponible en: https://www.elsevier.es/es-revista-neurologia-295-articulo-estudio-observacionalretrospectivo- sobre-efectividad-S0213485313001230

  14. Slof J, Díez Valle R, Galván J. Análisis coste-efectividad de la cirugía del glioma maligno guiada por fluorescencia con ácido 5-aminolevulínico. Neurología [Internet]. 2015[citado 18/08/2018];(3):30:163-168. Disponible en: https://www.elsevier.es/esrevista- neurologia-295-articulo-analisis-coste-efectividad-cirugia-del-glioma- S0213485313002867

  15. Castle M, Nájera E, Samprón N, et al. Biopsia cerebral estereotáctica sin marco: capacidad diagnóstica y complicaciones. Neurocirugía[Internet]. 2014[citado 08/08/2018];25(2):56–61. Disponible en: https://www.researchgate.net/publication/260914418_Biopsia_cerebral_estereotactica _sin_marco_capacidad_diagnostica_y_complicacione

  16. Eseonu CI, Rincon-Torroella J, ReFaey K, et al. Awake craniotomy vs. craniotomy under general anesthesia for perirolandic gliomas: Evaluating perioperative complications and extent of resection. Neurosurgery 2017;81(3):481–89. Citado en PubMed;PMID:28327900.

  17. Lau D, Hervey-Jumper SL, Han SJ, et al. Intraoperative perception and estimates on extent of resection during awake glioma surgery: Overcoming the learning curve. J Neurosurg. 2018;128(5):1–9.1410-1418. Citado en PubMed;PMID:28731401.

  18. Schwarzmaier HJ, Eickmeyer F, Von Tempelhoff W.et al. Mr-guided laser-induced interstitial thermotherapy of recurrent glioblastoma multiforme: Preliminary results in 16 patients. Eur J Radiol. 2006;59(2):208–215. Citado en PubMed;PMID:16854549.

  19. Martirosyan NL, Cavalcanti DD, Eschbacher JM, et al. Use of in vivo near-infrared laser confocal endomicroscopy with indocyanine green to detect the boundary of infiltrative tumor. J Neurosurg. 2011; 115(6):1131–38. Citado en PubMed;PMID:21923240.

  20. Pirro V, Alfaro CM, Jarmusch AK, et al. Intraoperative assessment of tumor margins during glioma resection by desorption electrospray ionization-mass spectrometry. Proc Natl Acad Sci USA 2017;114(26):6700–05. Citado en PubMed;PMID:28607048.

  21. Huang P. CBIO-20. GLIOBLASTOMA SPECIFIC PROTEINS IDENTIFIED THROUGH COMBINED IN VITRO AND IN VIVO PHAGE DISPLAY BIOPANNING. Neuro-Oncol. 2015;17(Supl5):v55–v65. Citado en PubMed;PMID:4638662.

  22. Sonikpreet A. CD38-targeted therapy in glioblastoma: A step forward. Neurology [Internet]. 2018[citado 08/08/2018];90(15). Disponible en: https://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.e14030

  23. Yang JM. Characterization of PTEN mutations in brain cancer reveals that pten mono-ubiquitination promotes protein stability and nuclear localization. Oncogene. 2017;36(26):3673–85. Citado en PubMed;PMID:28263967.

  24. Erasimus E, Gobin M, Niclou S, et al. DNA repair mechanisms and their clinical impact in glioblastoma. Mutat Res Rev Mutat Res.2016;769:19–35. Citado en PubMed;PMID:27543314.

  25. Kristoffersen K, Stockhausen M, Poulsen H. Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature. Cancer Biol Ther. 2014 Jul 1;15(7):862–877. Citado en PubMed;PMID:24755988.

  26. Pengcheng Li, Chun Zhou, Lunshan Xu, et al. Hypoxia Enhances Stemness of Cancer Stem Cells in Glioblastoma: An In Vitro Study. Int J Med Sci. 2013;10(4):399- 407. Citado en PubMed;PMID:23471193.




2020     |     www.medigraphic.com